Methicillin-Resistant S. aureus Infections among Patients in the Emergency Department
Open accessThe DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Methicillin-resistant Staphylococcus aureus (MRSA) is increasingly recognized in infections among persons in the community without established risk factors for MRSA. METHODS: We enrolled adult patients with acute, purulent skin and soft-tissue infections presenting to 11 university-affiliated emergency departments during the month of August 2004. Cultures were obtained, and clinical information was collected. Available S. aureus isolates were characterized by antimicrobial-susceptibility testing, pulsed-field gel electrophoresis, and detection of toxin genes. On MRSA isolates, we performed typing of the staphylococcal cassette chromosome mec (SCCmec), the genetic element that carries the mecA gene encoding methicillin resistance. RESULTS: S. aureus was isolated from 320 of 422 patients with skin and soft-tissue infections (76 percent). The prevalence of MRSA was 59 percent overall and ranged from 15 to 74 percent. Pulsed-field type USA300 isolates accounted for 97 percent of MRSA isolates; 74 percent of these were a single strain (USA300-0114). SCCmec type IV and the Panton-Valentine leukocidin toxin gene were detected in 98 percent of MRSA isolates. Other toxin genes were detected rarely. Among the MRSA isolates, 95 percent were susceptible to clindamycin, 6 percent to erythromycin, 60 percent to fluoroquinolones, 100 percent to rifampin and trimethoprim-sulfamethoxazole, and 92 percent to tetracycline. Antibiotic therapy was not concordant with the results of susceptibility testing in 100 of 175 patients with MRSA infection who received antibiotics (57 percent). Among methicillin-susceptible S. aureus isolates, 31 percent were USA300 and 42 percent contained pvl genes. CONCLUSIONS: MRSA is the most common identifiable cause of skin and soft-tissue infections among patients presenting to emergency departments in 11 U.S. cities. When antimicrobial therapy is indicated for the treatment of skin and soft-tissue infections, clinicians should consider obtaining cultures and modifying empirical therapy to provide MRSA coverage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“A recently published study of 422 patients with SSTI from 11 EDs in the United States reported that the prevalence of MRSA was 59%. 15”
From Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus skin and soft tissue infection in a Canadian emergency department (2009) · cites this paper as [15]
The cited source says what the claim attributes to it.
In the citing paper
“In other research, IDU was strongly linked to MRSA SSTI in homeless individuals, 7 but this association was not found in 2 ED-based studies. 8,15”
From Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus skin and soft tissue infection in a Canadian emergency department (2009) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lina, G., Piemont, Y., Godail-Gamot, F., Bes, M., Peter, M.-O., Gauduchon, V., Vandenesch, F., & Etienne, J. (1999) · Clinical Infectious Diseases · doi:10.1086/313461 · Cited by 2,489
Naimi, T. S. (2003) · JAMA · doi:10.1001/jama.290.22.2976 · Cited by 1,688
Methicillin-Resistant Staphylococcus aureus Disease in Three Communities
Fridkin, S. K., Hageman, J. C., Morrison, M., Sanza, L. T., Como-Sabetti, K., Jernigan, J. A., Harriman, K., Harrison, L. H., Lynfield, R., & Farley, M. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043252 · Cited by 1,493
Herold, B. C. (1998) · JAMA · doi:10.1001/jama.279.8.593 · Cited by 1,412
McDougal, L. K., Steward, C. D., Killgore, G. E., Chaitram, J. M., McAllister, S. K., & Tenover, F. C. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.11.5113-5120.2003 · Cited by 1,399
Self-citationA Clone of Methicillin-Resistant Staphylococcus aureus among Professional Football Players
Kazakova, S. V., Hageman, J. C., Matava, M., Srinivasan, A., Phelan, L., Garfinkel, B., Boo, T., McAllister, S., Anderson, J., Jensen, B., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042859 · Cited by 741
Self-citationFrancis, J. S., Doherty, M. C., Lopatin, U., Johnston, C. P., Sinha, G., Ross, T., Cai, M., Hansel, N. N., Perl, T., Ticehurst, J. R., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/427148 · Cited by 719
Barrett, F. F., McGehee, R. F., & Finland, M. (1968) · New England Journal of Medicine · doi:10.1056/nejm196808292790901 · Cited by 512
Frazee, B. W., Lynn, J., Charlebois, E. D., Lambert, L., Lowery, D., & Perdreau-Remington, F. (2005) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2004.10.011 · Cited by 494
Linezolid versus Vancomycin in Treatment of Complicated Skin and Soft Tissue Infections
Weigelt, J., Itani, K., Stevens, D., Lau, W., Dryden, M., & Knirsch, C. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.6.2260-2266.2005 · Cited by 457
Research works printed but not linked: 3
- 2003, MMWR Morb Mortal Wkly Rep, 52, 88
- Bannerman TL. Staphylococci and other catalase positive cocci that grow aerobically. In: Murray PR, Baron EJ, Jogensen JH, eds. Manual of clinical microbiology. 8th ed. Washington, D.C.: ASM Press, 2003:384-404.
- 10.1097/00006454-200307000-00006 · doi:10.1097/00006454-200307000-00006
Cited by
Items 201–300 of 1,001
May, L. S., Cosgrove, S. E., L'Archeveque, M., Talan, D. A., Payne, P. W., Jordan, J. A., & Rothman, R. E. (2012) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2012.09.002 · Cited by 163
Self-citationSpellberg, B., Ibrahim, A. S., Yeaman, M. R., Lin, L., Fu, Y., Avanesian, V., Bayer, A. S., Filler, S. G., Lipke, P., Otoo, H., et al. (2008) · Infection and Immunity · doi:10.1128/iai.00700-08 · Cited by 146
Exclusive Staphylococcus aureus Throat Carriage: At-Risk Populations
Mertz, D., Frei, R., Periat, N., Zimmerli, M., Battegay, M., Flückiger, U., & Widmer, A. F. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2008.536 · Cited by 124
Adhikari, R. P., Ajao, A. O., Aman, M. J., Karauzum, H., Sarwar, J., Lydecker, A. D., Johnson, J. K., Nguyen, C., Chen, W. H., & Roghmann, M.-C. (2012) · Journal of Infectious Diseases · doi:10.1093/infdis/jis462 · Cited by 144
A Serologic Correlate of Protective Immunity Against Community-Onset Staphylococcus aureus Infection
Fritz, S. A., Tiemann, K. M., Hogan, P. G., Epplin, E. K., Rodriguez, M., Al-Zubeidi, D. N., Wardenburg, J. B., & Hunstad, D. A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit123 · Cited by 154
Cephalosporins as key lead generation beta-lactam antibiotics
Lin, X., & Kück, U. (2022) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-022-12272-8 · Cited by 166
DeVries, A., Lesher, L. J., Schlievert, P. M., Rogers, T. B., Villaume, L. G., Danila, R., & Lynfield, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022997 · Cited by 161
Visible 405 nm SLD light photo‐destroys methicillin‐resistant Staphylococcus aureus (MRSA) in vitro
Enwemeka, C. S., Williams, D., Hollosi, S., Yens, D., & Enwemeka, S. K. (2008) · Lasers in Surgery and Medicine · doi:10.1002/lsm.20724 · Cited by 156
Han, L. L., McDougal, L. K., Gorwitz, R. J., Mayer, K. H., Patel, J. B., Sennott, J. M., & Fontana, J. L. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02274-06 · Cited by 142
Self-citationFritz, S. A., Hogan, P. G., Hayek, G., Eisenstein, K. A., Rodriguez, M., Epplin, E. K., Garbutt, J. M., & Fraser, V. J. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir919 · Cited by 147
Knight, G. M., Budd, E. L., Whitney, L., Thornley, A., Al-Ghusein, H., Planche, T., & Lindsay, J. A. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks245 · Cited by 158
ω-Hydroxyemodin Limits Staphylococcus aureus Quorum Sensing-Mediated Pathogenesis and Inflammation
Daly, S. M., Elmore, B. O., Kavanaugh, J. S., Triplett, K. D., Figueroa, M., Raja, H. A., El-Elimat, T., Crosby, H. A., Femling, J. K., Cech, N. B., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04564-14 · Cited by 138
Rasigade, J., Laurent, F., Lina, G., Meugnier, H., Bes, M., Vandenesch, F., Etienne, J., & Tristan, A. (2010) · The Journal of Infectious Diseases · doi:10.1086/652008 · Cited by 137
Palazzolo-Ballance, A. M., Reniere, M. L., Braughton, K. R., Sturdevant, D. E., Otto, M., Kreiswirth, B. N., Skaar, E. P., & DeLeo, F. R. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.1.500 · Cited by 142
MRSA in Conventional and Alternative Retail Pork Products
O'Brien, A. M., Hanson, B., Farina, S. A., Wu, J. Y., Simmering, J. E., Wardyn, S. E., Forshey, B. M., Kulick, M. E., Wallinga, D. B., & Smith, T. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030092 · Cited by 142
Planet, P. J., LaRussa, S. J., Dana, A., Smith, H., Xu, A., Ryan, C., Uhlemann, A.-C., Boundy, S., Goldberg, J., Narechania, A., et al. (2013) · mBio · doi:10.1128/mbio.00889-13 · Cited by 139
Epidemiological and resistance issues in multidrug-resistant staphylococci and enterococci
Leclercq, R. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02739.x · Cited by 160
Changing Susceptibility of Staphylococcus aureus in a US Pediatric Population
Sutter, D. E., Milburn, E., Chukwuma, U., Dzialowy, N., Maranich, A. M., & Hospenthal, D. R. (2016) · PEDIATRICS · doi:10.1542/peds.2015-3099 · Cited by 151
Role of Folate Antagonists in the Treatment of Methicillin-Resistant Staphylococcus aureus Infection
Goldstein, E. J. C., & Proctor, R. A. (2008) · Clinical Infectious Diseases · doi:10.1086/525536 · Cited by 138
“Thus, TMP-SMZ has been suggested for treatment of MRSA infection [13, 18, 19, 26, 27] because TMP-SMZ is inexpensive, is well tolerated, and penetrates well into tissues.”
BackgroundHan, G., Martinez, L. R., Mihu, M. R., Friedman, A. J., Friedman, J. M., & Nosanchuk, J. D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007804 · Cited by 133
Need and Potential of Antimicrobial Stewardship in Community Hospitals
Septimus, E. J., & Owens, R. C. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir363 · Cited by 127
Pantosti, A., & Venditti, M. (2009) · European Respiratory Journal · doi:10.1183/09031936.00007709 · Cited by 164
Hospital-associated MRSA and antibiotic resistance—What have we learned from genomics?
Lindsay, J. A. (2013) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2013.02.005 · Cited by 149
Staphylococcus aureus: A Community Pathogen
Miller, L. G., & Kaplan, S. L. (2009) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2008.10.002 · Cited by 149
Safety and Clinical Outcomes when Utilizing High-Dose (≥8 mg/kg) Daptomycin Therapy
Moise, P. A., Hershberger, E., Amodio-Groton, M. I., & Lamp, K. C. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1m085 · Cited by 136
Miller, L. G., Eells, S. J., Taylor, A. R., David, M. Z., Ortiz, N., Zychowski, D., Kumar, N., Cruz, D., Boyle‐Vavra, S., & Daum, R. S. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis213 · Cited by 130
Diagnosis and Management of Infection in the Diabetic Foot
Peters, E. J. G., & Lipsky, B. A. (2013) · Medical Clinics of North America · doi:10.1016/j.mcna.2013.04.005 · Cited by 142
Community-associated methicillin-resistant Staphylococcus aureus (MRSA) in Australia
Nimmo, G. R., & Coombs, G. W. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.08.011 · Cited by 145
Tenover, F. C., McAllister, S., Fosheim, G., McDougal, L. K., Carey, R. B., Limbago, B., Lonsway, D., Patel, J. B., Kuehnert, M. J., & Gorwitz, R. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00480-08 · Cited by 129
Self-citationTherapeutic applications of multifunctional nanozymes
Liu, X., Gao, Y., Chandrawati, R., & Hosta‐Rigau, L. (2019) · Nanoscale · doi:10.1039/c9nr06596b · Cited by 133
Ellis, M. W., Griffith, M. E., Dooley, D. P., McLean, J. C., Jorgensen, J. H., Patterson, J. E., Davis, K. A., Hawley, J. S., Regules, J. A., Rivard, R. G., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01086-06 · Cited by 129
Trends in Invasive Methicillin-Resistant Staphylococcus aureus Infections
Iwamoto, M., Mu, Y., Lynfield, R., Bulens, S. N., Nadle, J., Aragon, D., Petit, S., Ray, S. M., Harrison, L. H., Dumyati, G., et al. (2013) · Pediatrics · doi:10.1542/peds.2013-1112 · Cited by 127
Self-citationPallin, D. J., Binder, W. D., Allen, M. B., Lederman, M. M., Parmar, S., Filbin, M. R., Hooper, D. C., & Camargo, C. A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit122 · Cited by 134
Moise, P. A., North, D. S., Steenbergen, J. N., & Sakoulas, G. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70200-2 · Cited by 130
Life After USA300: The Rise and Fall of a Superbug
Planet, P. J. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw444 · Cited by 116
Stein, G. E., & Wells, E. M. (2010) · Current Medical Research and Opinion · doi:10.1185/03007990903512057 · Cited by 127
Limbago, B., Fosheim, G. E., Schoonover, V., Crane, C. E., Nadle, J., Petit, S., Heltzel, D., Ray, S. M., Harrison, L. H., Lynfield, R., et al. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.02264-08 · Cited by 125
Self-citationBassetti, M., Nicco, E., & Mikulska, M. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(09)70544-8 · Cited by 146
Relationship Between Maternal and Neonatal Staphylococcus aureus Colonization
Jimenez‐Truque, N., Tedeschi, S. K., Saye, E. J., McKenna, B. D., Langdon, W., Wright, J. P., Alsentzer, A., Arnold, S. R., Saville, B. R., Wang, W., et al. (2012) · PEDIATRICS · doi:10.1542/peds.2011-2308 · Cited by 137
Proteolytic Regulation of Toxin-Antitoxin Systems by ClpPC in Staphylococcus aureus
Donegan, N. P., Thompson, E. T., Fu, Z., & Cheung, A. L. (2010) · Journal of Bacteriology · doi:10.1128/jb.00233-09 · Cited by 121
Staphylococcus aureus is the most common identified cause of cellulitis: a systematic review
Chira, S., & Miller, L. G. (2009) · Epidemiology and Infection · doi:10.1017/s0950268809990483 · Cited by 124
Patients at Risk of Complications of Staphylococcus aureus Bloodstream Infection
del Río, A., Cervera, C., Moreno, A., Moreillon, P., & Miró, J. M. (2009) · Clinical Infectious Diseases · doi:10.1086/598187 · Cited by 142
Nygaard, T. K., Pallister, K. B., Dumont, A., DeWald, M., Watkins, R. L., Pallister, E. Q., Malone, C. L., Griffith, S., Horswill, A. R., Torres, V. J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036532 · Cited by 132
Development of a vaccine against Staphylococcus aureus
Spellberg, B. J., & Daum, R. (2011) · Seminars in Immunopathology · doi:10.1007/s00281-011-0293-5 · Cited by 134
Interleukin-36 in Infectious and Inflammatory Skin Diseases
Buhl, A.-L., & Wenzel, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01162 · Cited by 121
Future Challenges And Treatment Of Staphylococcus Aureus Bacteremia With Emphasis On MRSA
Rasmussen, R. V., Fowler, V. G., Skov, R. L., & Bruun, N. E. (2010) · Future Microbiology · doi:10.2217/fmb.10.155 · Cited by 144
Ruhe, J., & Menon, A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00262-07 · Cited by 137
Risk factors for nonpurulent leg cellulitis: a systematic review and meta-analysis
Quirke, M., Ayoub, F., McCabe, A., Boland, F., Smith, B., O’Sullivan, R., & Wakai, A. (2016) · British Journal of Dermatology · doi:10.1111/bjd.15186 · Cited by 121
Weber, S. G., Huang, S. S., Oriola, S., Huskins, W. C., Noskin, G. A., Harriman, K. H., Olmsted, R. N., Bonten, M. J. M., Lundstrom, T. S., Climo, M. W., et al. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.01.001 · Cited by 119
Pollack, C. V., Amin, A., Ford, W. T., Finley, R. W., Kaye, K. S., Nguyen, H., Rybak, M. J., & Talan, D. A. (2015) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2014.12.001 · Cited by 123
Self-citationClebak, K. T., & Malone, M. A. (2018) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2018.05.004 · Cited by 146
Shorr, A. F. (2007) · PharmacoEconomics · doi:10.2165/00019053-200725090-00004 · Cited by 140
Towards the immune proteome of Staphylococcus aureus – The anti-S. aureus antibody response
Holtfreter, S., Kolata, J., & Bröker, B. M. (2009) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2009.10.002 · Cited by 133
Alam, M. T., Read, T. D., Petit, R. A., Boyle-Vavra, S., Miller, L., Eells, S., Daum, R., & David, M. (2015) · mBio · doi:10.1128/mbio.00054-15 · Cited by 113
A Guide to Bacterial Culture Identification And Results Interpretation.
Giuliano, C. A., Patel, C. R., & Kale-Pradhan, P. B. (2019) · PubMed · Cited by 193
Rapid Antibiotic Susceptibility Testing in a Microfluidic pH Sensor
Tang, Y., Li, Z., Liu, J., & Wu, J. (2013) · Analytical Chemistry · doi:10.1021/ac303282j · Cited by 117
Weber, S. G., Huang, S. S., Oriola, S., Huskins, W. C., Noskin, G. A., Harriman, K., Olmsted, R. N., Bonten, M., Lundstrom, T., Climo, M. W., et al. (2007) · Infection Control & Hospital Epidemiology · doi:10.1086/512261 · Cited by 117
Yang, C., Luo, Y., Shen, H., Ge, M., Tang, J. L., Wang, Q., Lin, H., Shi, J., & Zhang, X. (2022) · Nature Communications · doi:10.1038/s41467-022-32405-x · Cited by 119
Garau, J., Ostermann, H., Medina, J., Avila, M. A. S., McBride, K., & Blasi, F. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12235 · Cited by 127
Prokocimer, P., Bien, P. A., Surber, J., Mehra, P., DeAnda, C., Bulitta, J. B., & Corey, G. R. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00076-10 · Cited by 115
Staphylococcal Skin and Soft Tissue Infections
Hatlen, T. J., & Miller, L. G. (2020) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2020.10.003 · Cited by 126
Methicillin-resistant Staphylococcus aureus: an overview for manual therapists
Green, B. N., Johnson, C. D., Egan, J. T., Rosenthal, M. D., Griffith, E. A., & Evans, M. W. (2012) · Journal of Chiropractic Medicine · doi:10.1016/j.jcm.2011.12.001 · Cited by 138
Current Treatment Options for Community‐Acquired Methicillin‐ResistantStaphylococcus aureusInfection
Moellering, R. C. (2008) · Clinical Infectious Diseases · doi:10.1086/529445 · Cited by 129
Jenkins, T. C., Knepper, B. C., Sabel, A. L., Sarcone, E., Long, J. A., Haukoos, J. S., Morgan, S. J., Biffl, W. L., Steele, A., Price, C. S., et al. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.29 · Cited by 122
Fate of antibiotic resistant genes in wastewater environments and treatment strategies - A review
Manoharan, R. K., Ishaque, F., & Ahn, Y. (2022) · Chemosphere · doi:10.1016/j.chemosphere.2022.134671 · Cited by 116
Monecke, S., Slickers, P., Ellington, M. J., Kearns, A., & Ehricht, R. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01833.x · Cited by 126
Long, D. R., Mead, J. S., Hendricks, J. M., Hardy, M. E., & Voyich, J. M. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01023-12 · Cited by 114
Tenover, F. C., Tickler, I. A., Goering, R. V., Kreiswirth, B. N., Mediavilla, J. R., & Persing, D. H. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05804-11 · Cited by 123
Montgomery, C. P., Daniels, M., Zhao, F., Alegre, M.-L., Chong, A. S., & Daum, R. S. (2014) · Infection and Immunity · doi:10.1128/iai.01491-14 · Cited by 109
Rehm, S. J., Boucher, H. W., Levine, D. P., Campion, M., Eisenstein, B. I., Vigliani, G. A., Corey, G. R., & Abrutyn, E. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn372 · Cited by 119
Improved understanding of factors driving methicillin-resistant Staphylococcus aureus epidemic waves
Otto, M. J., & Chatterjee (2013) · Clinical Epidemiology · doi:10.2147/clep.s37071 · Cited by 138
The Ess/Type VII secretion system of Staphylococcus aureus shows unexpected genetic diversity
Warne, B., Harkins, C. P., Harris, S. R., Vatsiou, A., Stanley-Wall, N., Parkhill, J., Peacock, S. J., Palmer, T., & Holden, M. T. G. (2016) · BMC Genomics · doi:10.1186/s12864-016-2426-7 · Cited by 110
Prevalence of antibiotic resistance in US hospitals
Edelsberg, J., Weycker, D. A., Barron, R., Li, X., Wu, H., Oster, G., Badre, S., Langeberg, W. J., & Weber, D. J. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.11.011 · Cited by 111
Arifuzzaman, M., Mobley, Y. R., Choi, H. W., Bist, P., Salinas, C. A., Brown, Z. D., Chen, S. L., Staats, H. F., & Abraham, S. N. (2019) · Science Advances · doi:10.1126/sciadv.aav0216 · Cited by 120
Mohammad, H. T., Mayhoub, A. S., Ghafoor, A., Soofi, M. A., Alajlouni, R. A., Cushman, M., & Seleem, M. N. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401905m · Cited by 112
McCaskill, M. L., Mason, E. O., Kaplan, S. L., Hammerman, W. A., Lamberth, L. B., & Hultén, K. G. (2007) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31814536e0 · Cited by 117
Tognetti, L., Martinelli, C. V., Berti, S., Hercogova, J. T., Lotti, T., Leoncini, F., & Moretti, S. (2012) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2011.04416.x · Cited by 111
Tranchemontagne, Z. R., Camire, R. B., O'Donnell, V. J., Baugh, J., & Burkholder, K. M. (2015) · Infection and Immunity · doi:10.1128/iai.00704-15 · Cited by 118
Moran, G. J., Krishnadasan, A., Gorwitz, R. J., Fosheim, G. E., Albrecht, V., Limbago, B., Talan, D. A., & for the EMERGEncy ID NET Study Group (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis022 · Cited by 110
Self-citationGhimire, L., Paudel, S., Jin, L., Baral, P., Cai, S., & Jeyaseelan, S. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007308 · Cited by 115
Management of common bacterial infections of the skin
Bernard, P. (2008) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3282f44c63 · Cited by 110
Feng, Z., Chakraborty, D., Dewell, S. B., Reddy, B. V. B., & Brady, S. F. (2012) · Journal of the American Chemical Society · doi:10.1021/ja207662w · Cited by 115
Vetter, R. S. (2008) · Journal of Arachnology · doi:10.1636/rst08-06.1 · Cited by 109
Wall teichoic acids mediate increased virulence in Staphylococcus aureus
Wanner, S., Schade, J., Keinhörster, D., Weller, N., George, S. E., Kull, L., Bauer, J., Grau, T., Winstel, V., Stoy, H., et al. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.257 · Cited by 118
Synthesis and Antimicrobial Activity of 4-Substituted 1,2,3-Triazole-Coumarin Derivatives
López-Rojas, P., Janeczko, M., Kubiński, K., Amesty, Á., Masłyk, M., & Estévez‐Braun, A. (2018) · Molecules · doi:10.3390/molecules23010199 · Cited by 108
van Sorge, N. M., Beasley, F. C., Gusarov, I., Gonzalez, D. J., von Köckritz-Blickwede, M., Anik, S., Borkowski, A. W., Dorrestein, P. C., Nudler, E., & Nizet, V. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.448738 · Cited by 103
Rogers, H. D., Desciak, E. B., Marcus, R. P., Wang, S., Mackay-Wiggan, J. M., & Eliezri, Y. D. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.07.029 · Cited by 107
Skin and Soft Tissue Infections Caused by Methicillin-Resistant Staphylococcus aureus USA300 Clone
Johnson, J. K., Khoie, T., Shurland, S., Kreisel, K., Stine, O. C., & Roghmann, M.-C. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1308.061575 · Cited by 104
Epidemiology and Outcomes of Complicated Skin and Soft Tissue Infections in Hospitalized Patients
Zervos, M., Freeman, K. D., Vo, L., Haque, N. Z., Pokharna, H., Raut, M. K., & Kim, M. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05817-11 · Cited by 113
Host-Pathogen Interactions in Gram-Positive Bacterial Pneumonia
Grousd, J. A., Rich, H. E. A., & Alcorn, J. F. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00107-18 · Cited by 107
Lee, T. C., Carrick, M. M., Scott, B. G., Hodges, J. C., & Pham, H. Q. (2007) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2007.08.047 · Cited by 105
Ray, G. T., Suaya, J. A., & Baxter, R. P. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.02.020 · Cited by 106
Goering, R. V., McDougal, L. K., Fosheim, G. E., Bonnstetter, K. K., Wolter, D. J., & Tenover, F. C. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00273-07 · Cited by 104
Self-citationCommunity-Associated Methicillin-Resistant Staphylococcus aureus
Gorwitz, R. J. (2008) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31818a3450 · Cited by 103
Self-citationTseng, C. W., Kyme, P., Low, J., Rocha, M. A., Alsabeh, R., Miller, L. G., Otto, M., Arditi, M., Diep, B. A., Nizet, V., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006387 · Cited by 103
Zhang, Y., Wang, Y., Chen, L., Zheng, J., Fan, X., Xu, X., Zhou, G., Ullah, N., & Feng, X. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121546 · Cited by 105
Staphylococcus aureus Protein A Promotes Immune Suppression
Kobayashi, S. D., & DeLeo, F. R. (2013) · mBio · doi:10.1128/mbio.00764-13 · Cited by 99
Cenizal, M. J., Skiest, D., Luber, S., Bedimo, R., Davis, P., Fox, P., Delaney, K., & Hardy, R. D. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00206-07 · Cited by 103
(2009) · Emerging Infectious Diseases · doi:10.3201/eid1512.081341 · Cited by 102
Moazzez, A. (2007) · Archives of Surgery · doi:10.1001/archsurg.142.9.881 · Cited by 102
Metadata
- Authors
- Moran, G. J., Krishnadasan, A., Gorwitz, R. J., Fosheim, G. E., McDougal, L. K., Carey, R. B., & Talan, D. A.
- Affiliations
- Olive View-UCLA Medical Center (US)
- Centers for Disease Control and Prevention (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2006-08-17
- Volume
- 355
- Issue
- 7
- Pages
- 666-674
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2131316809
- Cited by
- 2,285
- References
- 35
- Citations by year
- 2026: 28 · 2025: 39 · 2024: 58 · 2023: 39 · 2022: 42 · 2021: 55 · 2020: 57 · 2019: 76 · 2018: 83 · 2017: 72 · 2016: 93 · 2015: 125 · 2014: 117 · 2013: 145 · 2012: 170
- FWCI
- 138.69
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Centers for Disease Control and Prevention (U01CI000353)
- U.S. Public Health Service (U50/CCU912342)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
- Health Sciences › Medicine › Infectious Diseases › Dermatological diseases and infestations
- Keywords
- methicillin-resistant Staphylococcus aureus, skin and soft tissue infections, emergency department patients, community-acquired MRSA, USA300, Panton-Valentine leukocidin, antibiotic susceptibility, empirical antibiotic therapy, antimicrobial resistance, methicillin-susceptible Staphylococcus aureus
- MeSH terms
- Acute Disease, Adult, Aged, Anti-Bacterial Agents, Bacterial Proteins, Bacterial Toxins, Emergency Service, Hospital, Exotoxins, Female, Humans, Leukocidins, Male, Microbial Sensitivity Tests, Middle Aged, Staphylococcal Infections, Staphylococcal Skin Infections, Staphylococcus aureus, United States, Methicillin Resistance, Electrophoresis, Gel, Pulsed-Field, Soft Tissue Infections, Penicillin-Binding Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.